BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 9137461)

  • 1. IL-2 treatment of B16F10 melanoma cells stimulates metastatic colonization in the liver.
    Boyano MD; Garcia de Galdeano A; Smith-Zubiaga I; Cañavate ML
    Anticancer Res; 1997; 17(2A):1135-41. PubMed ID: 9137461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect induced by interleukin-1 on the behaviour of B16F10 melanoma cells.
    De Galdeano AG; Boyano D; Cañavate L
    Oncol Rep; 1999; 6(1):225-8. PubMed ID: 9864433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of interleukin-6 in the biology and metastatic activity of B16F10 melanoma cells.
    García de Galdeano ; Boyano D; Smith-Zubiaga I; Alvarez A; Cantón I; Cañavate L
    Eur Cytokine Netw; 1998 Jun; 9(2):187-92. PubMed ID: 9681395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
    Ouyang GF; Saio M; Suwa T; Imai H; Nakagawa J; Nonaka K; Umemura N; Kijima M; Takami T
    Int J Oncol; 2006 May; 28(5):1201-8. PubMed ID: 16596236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates.
    Cho D; Song H; Kim YM; Houh D; Hur DY; Park H; Yoon D; Pyun KH; Lee WJ; Kurimoto M; Kim YB; Kim YS; Choi I
    Cancer Res; 2000 May; 60(10):2703-9. PubMed ID: 10825144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.
    Kim TS; Cohen EP
    Cancer Res; 1994 May; 54(10):2531-5. PubMed ID: 8168073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for indirect involvement of the H-2Kb gene in the regulation of natural killer sensitivity of BL6 melanoma cells.
    Kim M; Herberman R; Gorelik E
    Nat Immun; 1994; 13(1):1-14. PubMed ID: 8111189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
    Cao X; Wang Q; Ju DW; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
    Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
    Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtherapeutic doses of interleukin-15 augment the antitumor effect of interleukin-12 in a B16F10 melanoma model in mice.
    Lasek W; Golab J; Maśliński W; Switaj T; Bałkowiec EZ; Stokłosa T; Giermasz A; Malejczyk M; Jakóbisiak M
    Eur Cytokine Netw; 1999 Sep; 10(3):345-56. PubMed ID: 10477391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
    Rodrigues EG; Garofalo AS; Travassos LR
    Cytokines Cell Mol Ther; 2002; 7(3):107-16. PubMed ID: 12850810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma.
    Kobayashi M; Kobayashi H; Pollard RB; Suzuki F
    J Immunol; 1998 Jun; 160(12):5869-73. PubMed ID: 9637498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
    Kim A; Jung JY; Son M; Lee SH; Lim JS; Chung AS
    Oncol Rep; 2008 Sep; 20(3):557-65. PubMed ID: 18695906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
    Wang G; Tschoi M; Spolski R; Lou Y; Ozaki K; Feng C; Kim G; Leonard WJ; Hwu P
    Cancer Res; 2003 Dec; 63(24):9016-22. PubMed ID: 14695220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells.
    Kozar K; Kaminski R; Giermasz A; Basak G; Zagozdzon R; Rybczynska J; Wasik M; Lasek W; Jakobisiak M; Golab J
    Oncol Rep; 2002; 9(2):427-31. PubMed ID: 11836621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor effect on melanoma by in vivo direct injection of packaging cells transfected recombinant IL-2 gene].
    Zhu Y; Wu Y; Hui Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):154-8. PubMed ID: 10453513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium.
    Carrascal MT; Mendoza L; Valcárcel M; Salado C; Egilegor E; Tellería N; Vidal-Vanaclocha F; Dinarello CA
    Cancer Res; 2003 Jan; 63(2):491-7. PubMed ID: 12543807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.